Your Meetings

NUVISAN events

Agenda

Digital Congress testing login url Gain in-depth understanding of your drug

January 3, 2022 at 1:04 PM CET

DAY 1 – Wed. December 1, 2021
4pm CET 10 Importance of understanding the assets MoA Charlotte Kopitz NUVISAN ICB
4:10pm CET 15 Pharmacological characterization of Antibody-drug-Conjugates (ADCs) Sven Golfier NUVISAN ICB
4:25pm CET 20 Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer Sebastian Dieter Netherlands Cancer Institute and DKFZ Heidelberg
4:45pm CET 20 PDE3A-SLFN12 complex formation for cancer therapy Heidi Greulich The Broad Institute of MIT and Harvard
5:05pm CET 15 Chemical probes as a validation tool to de-risk drug discovery & development: Exploring MENIN-MLL interaction as therapeutic target Carlo Stresemann NUVISAN ICB
5:20pm CET 35 Panel Discussion & Conclusion

Day 2 – Thurs. December 2, 2021
4pm CET 10 Importance of understanding the assets MoA Charlotte Kopitz NUVISAN ICB
4:10pm CET 15 Pharmacological characterization of Antibody-drug-Conjugates (ADCs) Sven Golfier NUVISAN ICB
4:25pm CET 20 Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer Sebastian Dieter Netherlands Cancer Institute and DKFZ Heidelberg
4:45pm CET 20 PDE3A-SLFN12 complex formation for cancer therapy Heidi Greulich The Broad Institute of MIT and Harvard
5:05pm CET 15 Chemical probes as a validation tool to de-risk drug discovery & development: Exploring MENIN-MLL interaction as therapeutic target Carlo Stresemann NUVISAN ICB
5:20pm CET 35 Panel Discussion & Conclusion

WE ARE HERE TO HELP

The NUVISAN team is happy to support you.

For sales enquiries, please schedule a meeting HERE or email us at hello@nuvisan.com.

For technical issues, please email us at marketing@nuvisan.com or call +49 731 9840 111.